Bird

In October 2014, Bird raised £133,694 through SyndicateRoom to expand its team and manufacture its high-performance, synthetic shuttlecock, Bird2.

The story

It is estimated that 200m shuttlecocks are sold every year. Through involvement in school and county badminton clubs, Gordon Willis conceived of a new shuttlecock that had the performance characteristics of a feather shuttle, but was still as durable as standard plastic shuttles and therefore significantly more economical.

Bird Design Ltd has developed several patented changes in shuttle design. Completely new moulding and assembly processes give a distinctively new looking, high performance, synthetic shuttle, branded as Bird2. This matches the playing characteristics of feather shuttles with greatly increased durability and performance consistency.

The company’s main product, Bird2, uses plastics instead of feathers. However, unlike other plastic shuttlecocks (which are banned from senior international tournaments for their inferiority), Bird2’s unique design gives it much more of the rigidity and ‘feel’ of a feather shuttle.

See current opportunities

Captive Media

EIS
Media & Telecommunications
Captive Media, the innovative company putting games into men's urinals, has successfully raised £300k from angels and sophisticated investors on SyndicateRoom.

Dissolved

Trading status

£13,261

Average investment

£305,000

Total raised

Captive Media

EIS
Media & Telecommunications
Captive Media, the innovative company putting games into men's urinals, has successfully raised over £323,216, in their second raise, from angels and sophisticated investors on SyndicateRoom.

Dissolved

Trading status

£9,794

Average investment

£323,216

Total raised

Canary

EIS
Technology, Hardware & Equipment
Canary is led by none other than Christopher Curry, co-founder of Acorn computers, William Cotton, former MD of Boots International, and Stuart Sheehy, previously at BUPA.

Dissolved

Trading status

£10,458

Average investment

£251,000

Total raised

Bactest

EIS
Pharmaceuticals & Biotechnology
Bactest’s technology turns microbial activity into data, offering multiple industry applications. They raised £838,380.

Dissolved

Trading status

£13,478

Average investment

£930,000

Total raised

Apta Bioscience

EIS
Pharmaceuticals & Biotechnology
Apta Biosciences – creators of a groundbreaking alternative to antibodies – came to SyndicateRoom for help closing their £1.55 million round. The spin-off from Japanese IT giant Fujitsu wound up breezing past their funding target, closing at an impressive £1,792,500.

Active

Trading status

£34,906

Average investment

£1,850,000

Total raised